Switching from Wegovy Injection to the Wegovy Pill: How It Works

Can I switch from the Wegovy injection to the pill?

Yes, you can switch from the Wegovy injection to the pill. Wegovy is the only GLP-1 weight loss medication with a published switching protocol from its manufacturer, Novo Nordisk. 

The guidance covers moving in both directions: from injection to pill, or pill to injection. The two formats contain the same active ingredient, semaglutide. They simply deliver it to your bloodstream in different ways.

The U.S. Food and Drug Administration (FDA) approved the Wegovy pill in December 2025. Launch followed in January 2026. The UK Medicines and Healthcare products Regulatory Agency (MHRA) has now approved oral semaglutide for sale in the UK.

Most people who switch from the Wegovy jab to the pill do it for convenience, not for effectiveness. Needle anxiety or fatigue is a real issue for many, and the chance to switch to a tablet is appealing. Others simply prefer a daily routine to weekly injections. Wegovy pills are one of the few weight loss treatments available in oral form.

How do I switch from the Wegovy injection to the pill?

If you are on the 2.4mg Wegovy maintenance injection, the FDA switching protocol is straightforward. One week after your final injection, start at 25mg of the semaglutide tablet once daily.

Step 1. Take your final 2.4mg injection as you normally would.

Step 2. Wait seven days.

Step 3. The following week,on your next scheduled injection day, start the 25mg Wegovy tablet. Take it first thing in the morning on an empty stomach, with no more than 120ml of plain water.

Step 4. Wait 30 minutes before you eat, drink, or take other oral medications.

Step 5. Repeat this routine at roughly the same time every morning.

The 25mg tablet and the 2.4mg weekly injection have a broadly similar effect on the body.

What if I am not at the 2.4mg maintenance dose?

If you have not yet reached the 2.4mg maintenance injection, you will need to use a different dose and continue to titrate up.

Wegovy Injection Dose	Wegovy Pill Dose
7.2mg, 2.4mg or 1.7mg	25mg
0.5mg or 1mg	9mg
0.25mg	4mg
–	1.5mg

You then follow the full Wegovy pill dose escalation schedule up to maintenance. 

Wegovy tablets come in four strengths (1.5mg, 4mg, 9mg, and 25mg) for the gradual build-up. The escalation runs over four months, with each step lasting 30 days:

Days	Dose	Phase
Days 1 to 30	1.5mg once daily	Starting dose
Days 31 to 60	4mg once daily	Escalation
Days 61 to 90	9mg once daily	Escalation
Day 91 onwards	25mg once daily	Maintenance dose

If a step up is not well tolerated, the escalation pauses at the lower dose for another 30 days. Side effects from each new dose tend to ease within the first few weeks.

What should I expect during the switch?

Most people do not notice a dramatic change in appetite when they switch. The 2.4mg injection and 25mg tablet work similarly, so the medication continues doing what it was doing.

The fasting routine is the part most people get wrong. The rule itself is simple, but the slip-ups are easy. 

Coffee or tea before the tablet breaks the rule. So does eating breakfast within the 30-minute window. Food and other liquids interfere with absorption more than many people expect.

Consuming anything other than a small amount of water can dilute the pill and destroy the absorption enhancer. This means the pill’s effects will be drastically reduced or even entirely cancelled out. It will be much less effective at controlling your appetite.

Most patients adapt to the daily routine within the first few weeks. But if you travel often or have unpredictable mornings, the fasting rules may be harder to keep up with. A weekly injection is easier to stay on top of.

The most common side effects of both formats are nausea, vomiting, diarrhoea, and constipation. How and when they appear can differ when you switch. The injection releases semaglutide slowly over the week. The pill releases smaller amounts each morning. 

This means semaglutide levels rise after each injection and slowly drop over the week until the next dose. With the daily tablet, levels of semaglutide will rise and fall over a much shorter timeframe. The impact of these patterns in practice varies from person to person.

If side effects of the Wegovy pill worsen or the daily routine becomes hard to maintain, you can switch back to the injection. 

Can I switch back from the pill to the injection?

The FDA protocol supports switching back to the injection. The day after your final 25mg Wegovy tablet, you start the 2.4mg subcutaneous injection once weekly. No washout week is needed in this direction. Both the injection and tablets remain in your system for the same amount of time.

If you cannot tolerate the 25mg tablet, the FDA recommends a lower-dose injection instead. The 1.7mg weekly injection sits one step below maintenance. Starting lower is often easier to tolerate than higher doses.

Will my weight change during the switch?

Small weight fluctuations after switching are common. A kilogram or two in either direction during the first few weeks rarely means the switch has failed. Most people see their weight loss continue at a similar pace in the long term. 

The two trial figures sit close together. In the OASIS 4 clinical trial, the 25mg semaglutide tablet produced an average weight loss of ~17% over 64 weeks in adults with obesity or overweight without diabetes. The STEP 1 trial of the 2.4mg weekly injection also produced ~17% over 68 weeks.

If you were already losing weight steadily on the injection, the pill picks up where the injection left off. A plateau is harder to shift. Switching from injection to pill is unlikely to kick-start weight loss that has stalled.

How well you absorb the pill matters more than it does with the injection. The 30-minute fast, the limit on water volume, and the rule about no other drinks all affect how much semaglutide reaches your bloodstream. Patients who keep to the routine tend to keep losing weight. Patients who slip into morning coffee before the tablet often see results plateau.

Talk to us if your weight rises steadily over several weeks. The tablet may not be working as effectively for you as the injection did. 

Real-world data comparing the Wegovy pill vs the injection is still emerging.

When should I see a doctor?

Talk to us or another healthcare professional about persistent nausea or vomiting that still allows you to keep fluids down. Mild diarrhoea, constipation, or reflux lasting more than a few days is also worth flagging. So is any change in appetite that concerns you. 

If you are struggling to adjust to the fasting routine, let us know before things slip. We can help you work out whether to keep going, adjust the dose, pause, or switch back to the injection. 

Contact your GP or call NHS 111 the same day for symptoms that need urgent assessment:

• A new lump in your neck, persistent hoarseness, or trouble swallowing. These symptoms may indicate thyroid problems
• Yellowing of the skin or eyes
• Severe pain in the upper-right abdomen, which can be a sign of gallbladder problems
• Vomiting that stops you from keeping fluids down for more than 24 hours
• Signs of low blood sugar (sweating, shakiness, confusion) if you also take insulin

Stop Wegovy and call 999 or go to A&E if you notice any of these:

• Severe abdominal pain spreading to your back, especially with vomiting (possible pancreatitis)
• Facial, lip, tongue, or throat swelling, or difficulty breathing
• Severe dehydration: dizziness, dark urine, or no fluids staying down

Key takeaways

• You can switch directly from Wegovy injections to Wegovy pills. Which strength you switch to will depend on what dose you are currently taking.
• The switch in practice: one week after your final Wegovy injection, you start the Wegovy pill once daily.
• The fasting routine catches more people out than the medication change itself.
• Oral Wegovy was FDA-approved in December 2025, but UK availability is still pending MHRA approval.

References

Wegovy (semaglutide) Prescribing Information (NDA 218316), U.S. Food and Drug Administration, 2025 [Accessed 18 May 2026]

Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity (OASIS 4), New England Journal of Medicine, 2025 [Accessed 18 May 2026]

Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1), New England Journal of Medicine, 2021 [Accessed 18 May 2026] 

GLP-1 medicines for weight loss and diabetes: what you need to know, Medicines and Healthcare products Regulatory Agency, GOV.UK, 2026 [Accessed 18 May 2026]

FDA approves Novo Nordisk’s Wegovy pill, the first and only oral GLP-1 for weight loss in adults, Novo Nordisk press release, 2025 [Accessed 18 May 2026]

Authorship